文献速递乳房整形与再造显微修复重建创面修复

乳房淋巴水肿的外科治疗:一种具有独特挑战的独立病理

Surgical Treatment of Breast Lymphedema: A Distinct Pathology With Unique Challenges.
PubMed 文献 · Ann Plast Surg · 2024-01-01

本研究前瞻性纳入2020年9月至2023年5月转诊至本机构的9例乳房淋巴水肿患者,其中8例曾接受保乳术加全乳放疗,1例因霍奇金淋巴瘤接受腋窝淋巴结清扫加腋窝放疗。3例接受手术治疗:1例无旁路靶点者行乳房缩小术后部分症状缓解, later行乳房切除加腹部游离皮瓣重建及腹股沟血管化淋巴结移植;2例有合适旁路靶点者行淋巴静脉旁路后乳房肿胀及主观症状消退。作者认为乳房淋巴水肿因辐射场效应导致弥漫性淋巴管闭塞,其病理生理与肢体淋巴水肿不同,乳房切除等切除策略和血管化淋巴结移植等再生技术应被视为潜在的一线治疗选择。

要点

  • 乳房淋巴水肿多继发于保乳术加全乳放疗,淋巴管弥漫性闭塞。
  • 吲哚菁绿淋巴造影可用于评估淋巴静脉旁路手术候选资格。
  • 无旁路靶点者可选择乳房切除加游离皮瓣重建及血管化淋巴结移植。

核心结论

  • 乳房淋巴水肿因辐射场效应导致弥漫性淋巴管闭塞,其病理生理与肢体淋巴水肿不同。
  • 已发表的外科治疗报告几乎仅描述淋巴静脉旁路,但其他手术选择可能更常被需要。
  • 作者认为乳房切除等切除策略和血管化淋巴结移植等再生技术应被视为这些患者的潜在一线治疗选择。

研究设计与样本

  • 前瞻性维护数据库,纳入2020年9月至2023年5月转诊至本机构的所有乳房淋巴水肿患者。
  • 乳房淋巴水肿采用临床标准诊断,所有患者包括手术治疗者均接受综合消肿治疗。
  • 共纳入9例患者,其中8例曾接受保乳术加全乳放疗,1例因霍奇金淋巴瘤接受腋窝淋巴结清扫加腋窝放疗。

主要发现

  • 6例患者行吲哚菁绿淋巴造影,其中4例显示弥漫性真皮回流。
  • 2例患者有适合淋巴静脉旁路的淋巴靶点,包括1例未接受乳房放疗的患者。
  • 3例患者接受手术治疗:1例无旁路靶点者行乳房缩小术后部分症状缓解,后行乳房切除加腹部游离皮瓣重建及血管化淋巴结移植;2例有合适旁路靶点者行淋巴静脉旁路后乳房肿胀及主观症状消退。

临床怎么用

  • 作者认为乳房切除等切除策略和血管化淋巴结移植等再生技术应被视为这些患者的潜在一线治疗选择。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Supermicrosurgical advances such as lymphovenous bypass (LVB) have enabled effective physiologic treatment of lymphedema affecting the extremities. Reports of surgical treatment for breast lymphedema (BL) are sparse, consisting of case reports and almost exclusively LVB. We report our experience with BL, including a case of mastectomy and breast reconstruction with abdominal free flap and inguinal vascularized lymph node transfer (VLNT) for BL. We compare our series with the surgical literature to discern unique characteristics and treatment limitations inherent to this disease. METHODS: A database was prospectively maintained from September 2020 to May 2023 including all patients diagnosed with BL who were referred to our institution. Breast lymphedema was diagnosed using clinical criteria, and relevant patient data were recorded. Patients interested in surgical management underwent indocyanine green lymphography to determine candidacy for LVB or other interventions. All patients, including those surgically managed, were treated with complex decongestive therapy. RESULTS: Nine patients with BL were included. Eight had undergone breast-conserving therapy for breast cancer with whole breast irradiation. One patient was treated for Hodgkin lymphoma with axillary lymphadenectomy and axillary radiation. Indocyanine green lymphography was performed in 6 patients, of which 4 patients had diffuse dermal backflow. Two patients had lymphatic targets suitable for LVB, including the patient without breast irradiation. Three patients were managed surgically. One patient without bypass targets underwent breast reduction with partial symptomatic relief, later followed by a mastectomy with abdominal free flap reconstruction and VLNT. Two patients with suitable bypass targets underwent LVB, with resolution of breast swelling and subjective symptoms. CONCLUSIONS: The diffuse lymphatic obliteration due to radiation field effect in BL results in a distinct pathophysiology compared with extremity lymphedema. Although published reports of surgical BL treatment almost exclusively describe LVB, other surgical options may be more frequently required. Ablative strategies such as mastectomy and regenerative techniques such as VLNT should be considered potential first-line treatment options for these patients.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Szymanski K, Chun Fat S, Brazio PS, et al. Surgical Treatment of Breast Lymphedema: A Distinct Pathology With Unique Challenges. Ann Plast Surg. 2024. PMID: 38689412. doi:10.1097/SAP.0000000000003817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。